BR112012004395A2 - liberação de sdf-1 para tratamento do tecido isquêmico - Google Patents
liberação de sdf-1 para tratamento do tecido isquêmicoInfo
- Publication number
- BR112012004395A2 BR112012004395A2 BR112012004395A BR112012004395A BR112012004395A2 BR 112012004395 A2 BR112012004395 A2 BR 112012004395A2 BR 112012004395 A BR112012004395 A BR 112012004395A BR 112012004395 A BR112012004395 A BR 112012004395A BR 112012004395 A2 BR112012004395 A2 BR 112012004395A2
- Authority
- BR
- Brazil
- Prior art keywords
- sdf
- release
- tissue treatment
- ischemic tissue
- ischemic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23777509P | 2009-08-28 | 2009-08-28 | |
US61/237,775 | 2009-08-28 | ||
US33421610P | 2010-05-13 | 2010-05-13 | |
US61/334,216 | 2010-05-13 | ||
PCT/US2010/047175 WO2011026041A2 (en) | 2009-08-28 | 2010-08-30 | Sdf-1 delivery for treating ischemic tissue |
Publications (3)
Publication Number | Publication Date |
---|---|
BR112012004395A2 true BR112012004395A2 (pt) | 2016-11-16 |
BR112012004395B1 BR112012004395B1 (pt) | 2021-01-12 |
BR112012004395B8 BR112012004395B8 (pt) | 2021-05-25 |
Family
ID=43628693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012004395A BR112012004395B8 (pt) | 2009-08-28 | 2010-08-30 | plasmídeo fator 1 derivado de célula de estroma (sdf-1) e preparação injetável compreendendo referido plasmídeo |
Country Status (9)
Country | Link |
---|---|
US (5) | US20120283315A1 (pt) |
EP (1) | EP2473196B1 (pt) |
JP (1) | JP5856059B2 (pt) |
CN (1) | CN102740894B (pt) |
AU (1) | AU2010286511B2 (pt) |
BR (1) | BR112012004395B8 (pt) |
CA (1) | CA2772610C (pt) |
MX (1) | MX357779B (pt) |
WO (1) | WO2011026041A2 (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050271639A1 (en) * | 2002-08-22 | 2005-12-08 | Penn Marc S | Genetically engineered cells for therapeutic applications |
EP2142206B1 (en) | 2007-03-30 | 2014-07-30 | The Cleveland Clinic Foundation | SDF-1 for use in the treatment of ischemic peripheral vascular disorders |
US20100272679A1 (en) | 2007-12-14 | 2010-10-28 | Penn Marc S | Compositions and methods of promoting wound healing |
CA2772610C (en) | 2009-08-28 | 2018-01-23 | The Cleveland Clinic Foundation | Sdf-1 delivery for treating ischemic tissue |
US9308277B2 (en) | 2010-02-25 | 2016-04-12 | Mesoblast International Sàrl | Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |
JP5921558B2 (ja) * | 2010-10-14 | 2016-05-24 | ユニバーシティ オブ セントラル フロリダ リサーチ ファウンデーション,インコーポレイテッド | 心臓人工多能性幹細胞ならびに心筋の修復および再生に使用する方法 |
US20130136729A1 (en) * | 2011-11-11 | 2013-05-30 | University of Virginia Patent Foundation, d/b/a University of Virginia Licensing & Ventures Group | Compositions and methods for targeting and treating diseases and injuries using adeno-associated virus vectors |
US20160024521A1 (en) * | 2013-03-15 | 2016-01-28 | The Cleveland Clinic Foundation | Retrograde delivery of sdf-1 for treatment of myocardial infarction |
EP2970941A4 (en) * | 2013-03-15 | 2016-11-30 | Cleveland Clinic Foundation | SDF-1 ADMINISTRATION FOR THE TREATMENT OF ISCHEMIC TISSUE |
KR20160005333A (ko) * | 2013-03-15 | 2016-01-14 | 유벤타스 세라퓨틱스, 인크. | 흉터 형성을 완화시키기 위한 sdf-1의 용도 |
US10166044B1 (en) | 2013-05-31 | 2019-01-01 | Freshwater Bay Industries, Llc | Apparatus for repositioning the vagina, cervix, uterus and pelvic floor and method to secure same |
US20160278810A1 (en) | 2013-05-31 | 2016-09-29 | Mark Edmund Richey | Vaginal surgical apparatus |
US20170049856A1 (en) * | 2014-04-28 | 2017-02-23 | Juventas Therapeutics, Inc. | Sdf-1 delivery for treating advanced ischemic cardiomyopathy |
JP2017514875A (ja) | 2014-05-08 | 2017-06-08 | ウェイク・フォレスト・ユニヴァーシティ・ヘルス・サイエンシズ | 失禁および他の括約筋不全障害を処置する方法 |
AU2015370982B2 (en) | 2014-12-23 | 2019-03-21 | Ilya Pharma Ab | Methods for wound healing |
CA3004742A1 (en) | 2015-11-11 | 2017-05-18 | Intrexon Corporation | Compositions and methods for expression of multiple biologically active polypeptides from a single vector for treatment of cardiac conditions and other pathologies |
CA3055761A1 (en) * | 2017-03-30 | 2018-10-04 | Wake Forest University Health Sciences | Methods of treatment for kidney disease |
US11583571B2 (en) | 2017-05-13 | 2023-02-21 | The Johns Hopkins University | Stromal derived factor 1 and its use in the prevention and treatment of erectile dysfunction |
US11654181B2 (en) | 2017-08-11 | 2023-05-23 | Wake Forest University Health Sciences | Use of CXCL12 for therapy after prostate surgery |
Family Cites Families (81)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
ATE159548T1 (de) | 1990-11-13 | 1997-11-15 | Immunex Corp | Bifunktionelle wählbare fusionsgene |
US5197985A (en) | 1990-11-16 | 1993-03-30 | Caplan Arnold I | Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells |
EP0804590A1 (en) | 1993-05-21 | 1997-11-05 | Targeted Genetics Corporation | Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene |
US20020031803A1 (en) * | 1997-06-20 | 2002-03-14 | Cooper Mark J. | Expression system for production of therapeutic proteins |
US5602301A (en) | 1993-11-16 | 1997-02-11 | Indiana University Foundation | Non-human mammal having a graft and methods of delivering protein to myocardial tissue |
EP0760682A4 (en) | 1995-02-28 | 1998-09-09 | Univ California | ANGIOGENIC THERAPY BY GENE TRANSFER |
US6121246A (en) | 1995-10-20 | 2000-09-19 | St. Elizabeth's Medical Center Of Boston, Inc. | Method for treating ischemic tissue |
US5980887A (en) | 1996-11-08 | 1999-11-09 | St. Elizabeth's Medical Center Of Boston | Methods for enhancing angiogenesis with endothelial progenitor cells |
WO1998032859A1 (en) * | 1997-01-29 | 1998-07-30 | Cornell Research Foundation, Inc. | Multiple site delivery of adenoviral vector for the induction of angiogenesis |
US6121428A (en) | 1997-06-13 | 2000-09-19 | Genentech, Inc. | Protein recovery |
MXPA00003885A (es) | 1997-10-22 | 2004-04-23 | Inst Genetics Llc | Quimiocinas con modificiaciones de la terminacion amino. |
US20030129750A1 (en) * | 1998-02-05 | 2003-07-10 | Yitzhack Schwartz | Homing of donor cells to a target zone in tissue using active therapeutics or substances |
AU767662B2 (en) | 1998-02-06 | 2003-11-20 | Collateral Therapeutics, Inc. | Variants of the angiogenic factor vascular endothelial cell growth factor: VEGF |
EP1061800A4 (en) | 1998-03-09 | 2004-10-06 | Caritas St Elizabeths Boston | COMPOSITIONS AND METHODS FOR MODULATING THE VASCULARIZATION |
US6676937B1 (en) | 1998-03-09 | 2004-01-13 | Caritas St. Elizabeth's Medical Center Of Boston Inc. | Compositions and methods for modulating vascularization |
AU766675B2 (en) | 1998-03-30 | 2003-10-23 | Northwest Biotherapeutics, Inc. | Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis |
US20020107195A1 (en) | 1998-07-21 | 2002-08-08 | Smithkline Beecham Corporation | Method for inducing chemotaxis in endothelial cells by administering stromal cell derived factor-1alpha |
IL125532A0 (en) | 1998-07-27 | 1999-03-12 | Yeda Res & Dev | Hematopoietic cell composition for use in transplantation |
AU5241099A (en) | 1998-07-31 | 2000-02-21 | Trustees Of Columbia University In The City Of New York, The | Use of inhibitors of the activation of cxcr4 receptor by sdf-1 in treating rheumatoid arthritis |
WO2000015285A1 (en) * | 1998-09-14 | 2000-03-23 | Mirus Corporation | A process for delivering nucleic acids to cardiac tissue |
DE19844479C1 (de) | 1998-09-28 | 2000-04-13 | Siemens Ag | Integrierter Speicher mit einem differentiellen Leseverstärker |
US7399751B2 (en) | 1999-11-04 | 2008-07-15 | Sertoli Technologies, Inc. | Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells |
EP1013770A1 (en) * | 1998-12-23 | 2000-06-28 | Université Louis Pasteur de Strasbourg | Non-viral transfection vector |
DE19900743A1 (de) * | 1999-01-12 | 2000-07-13 | Aventis Pharma Gmbh | Neue komplexbildende Proteine |
WO2000041732A1 (en) | 1999-01-19 | 2000-07-20 | The Children's Hospital Of Philadelphia | Hydrogel compositions for controlled delivery of virus vectors and methods of use thereof |
WO2000050048A2 (en) | 1999-02-26 | 2000-08-31 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Bone marrow transplantation for hepatic regeneration and repair |
US20050153451A1 (en) * | 1999-02-26 | 2005-07-14 | Wolff Jon A. | Intravascular delivery of non-viral nucleic acid |
EP1041148A1 (en) | 1999-04-02 | 2000-10-04 | Mogen International N.V. | Pathogen inducible promoter |
AU4230900A (en) | 1999-04-08 | 2000-10-23 | General Hospital Corporation, The | Purposeful movement of human migratory cells away from an agent source |
US7125856B1 (en) | 1999-04-15 | 2006-10-24 | St. Elizabeth's Medical Center Of Boston, Inc. | Angiogenic growth factors for treatment of peripheral neuropathy |
US6358697B2 (en) | 1999-04-21 | 2002-03-19 | Children's Hospital Medical Center | Intracellular pharmaceutical targeting |
AU4801501A (en) * | 2000-05-26 | 2001-11-29 | Transgene S.A. | Complex for transferring an anionic substance of interest into a cell |
JP5414958B2 (ja) | 2000-06-05 | 2014-02-12 | ザ・トラスティーズ・オブ・コランビア・ユニバーシティー・イン・ザ・シティー・オブ・ニューヨーク | ヒト骨髄由来内皮前駆細胞の同定、及び虚血性傷害後の心筋細胞の機能を改善するためのヒト骨髄由来内皮前駆細胞の使用 |
AU2001284695A1 (en) | 2000-07-31 | 2002-02-13 | New York Medical College | Methods and compositions for the repair and/or regeneration of damaged myocardium |
CN1211126C (zh) * | 2000-08-04 | 2005-07-20 | 人体基因组科学有限公司 | 血管内皮生长因子2 |
US20040009940A1 (en) * | 2000-10-20 | 2004-01-15 | Coleman Michael E. | Gene delivery formulations and methods for treatment of ischemic conditions |
US7402567B2 (en) | 2000-10-27 | 2008-07-22 | The Regents Of The University Of California | Treatment of disease by inducing cell apoptosis |
AU2002235168A1 (en) | 2000-11-05 | 2002-05-15 | University Of Florida | Targeting pluripotent stem cells to tissues |
ATE287945T1 (de) | 2000-11-14 | 2005-02-15 | Univ Bruxelles | Herstellung und verwendung von dendritischen zellen |
JP2004517078A (ja) | 2000-12-01 | 2004-06-10 | シェーリング コーポレイション | 哺乳動物遺伝子および関連試薬の使用 |
AR027161A1 (es) * | 2001-05-15 | 2003-03-19 | Bio Sidus S A | Metodo para inducir la proliferacion neovascular y regeneracion tisular |
US7399740B2 (en) | 2001-06-28 | 2008-07-15 | Yeda Research And Development Co. Ltd. | Poly-Glu,Tyr for neuroprotective therapy |
CN1564864A (zh) | 2001-08-07 | 2005-01-12 | 麒麟麦酒株式会社 | 造血干细胞的制备方法 |
EP1430114B1 (en) | 2001-09-14 | 2012-01-18 | Stem Cell Therapeutics Inc. | Prolactin induced increase in neural stem cell numbers and therapeutical use thereof |
US7402724B2 (en) | 2002-01-04 | 2008-07-22 | Mayo Foundation For Medical Education And Research | Longevity and PAPP-A |
AU2002226683A1 (en) | 2002-01-17 | 2003-07-30 | Cardio Incorporated | Complex therapy for tissue regeneration |
FR2843697B1 (fr) * | 2002-08-26 | 2005-12-09 | Sod Conseils Rech Applic | L'heterocarpine, une proteine d'origine vegetale aux proprietes anticancereuses |
US7396537B1 (en) | 2002-02-28 | 2008-07-08 | The Trustees Of The University Of Pennsylvania | Cell delivery patch for myocardial tissue engineering |
AU2003225791A1 (en) | 2002-03-15 | 2003-09-29 | Department Of Veterans Affairs, Rehabilitation R And D Service | Methods and compositions for directing cells to target organs |
US20030199464A1 (en) | 2002-04-23 | 2003-10-23 | Silviu Itescu | Regeneration of endogenous myocardial tissue by induction of neovascularization |
US20040161412A1 (en) * | 2002-08-22 | 2004-08-19 | The Cleveland Clinic Foundation | Cell-based VEGF delivery |
US20050271639A1 (en) | 2002-08-22 | 2005-12-08 | Penn Marc S | Genetically engineered cells for therapeutic applications |
US20040037811A1 (en) | 2002-08-22 | 2004-02-26 | The Cleveland Clinic Foundation | Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy |
JP2004099471A (ja) | 2002-09-05 | 2004-04-02 | Cardio Corp | 心筋梗塞および心不全の治療薬 |
US7393628B2 (en) | 2002-10-08 | 2008-07-01 | American National Red Cross | Method for enriching adherent monocyte populations |
JP2006505380A (ja) | 2002-11-05 | 2006-02-16 | ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド | 間葉幹細胞およびその使用方法 |
US20040258670A1 (en) | 2002-12-05 | 2004-12-23 | Case Western Reserve University | Cell-based therapies for ischemia |
JPWO2004074494A1 (ja) * | 2003-02-19 | 2006-06-01 | 株式会社ディナベック研究所 | 虚血疾患の治療方法 |
AU2003902037A0 (en) | 2003-04-24 | 2003-05-15 | Mclachlan, Craig | Method for tissue growth |
US20050104072A1 (en) | 2003-08-14 | 2005-05-19 | Slater David B.Jr. | Localized annealing of metal-silicon carbide ohmic contacts and devices so formed |
US7396680B2 (en) | 2003-10-31 | 2008-07-08 | Cornell Research Foundation, Inc. | Stem cell-specific promoters and their use |
IL158868A0 (en) | 2003-11-13 | 2004-05-12 | Yeda Res & Dev | Methods of generating and using stem cells enriched with immature primitive progenitor |
WO2005062881A2 (en) * | 2003-12-24 | 2005-07-14 | Transgenrx, Inc. | Gene therapy using transposon-based vectors |
CA2571315C (en) | 2004-06-21 | 2017-02-14 | The Cleveland Clinic Foundation | Ccr ligands for stem cell homing |
US20090285785A1 (en) | 2004-09-17 | 2009-11-19 | Cellgentech, Inc. | External Agent for Treatment of Skin Ulcer |
EP1804813A4 (en) * | 2004-09-27 | 2011-09-07 | Vical Inc | FORMULATIONS AND METHOD FOR THE TREATMENT OF INFLAMMATORY DISEASES |
US20060105950A1 (en) | 2004-10-25 | 2006-05-18 | Caritas St. Elizabeth's Medical Center Of Boston, Inc. | Morphogen compositions and use thereof to treat wounds |
WO2006083394A2 (en) | 2004-12-21 | 2006-08-10 | Ethicon, Inc. | Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same |
US7951632B1 (en) | 2005-01-26 | 2011-05-31 | University Of Central Florida | Optical device and method of making |
GB2424312B (en) | 2005-03-14 | 2010-03-03 | Denso Corp | Method of forming an ohmic contact in wide band semiconductor |
EP2546865B1 (en) | 2005-09-16 | 2023-12-06 | Wolfspeed, Inc. | Methods of processing semiconductor wafers having silicon carbide power devices thereon |
EP2264741B1 (en) | 2006-01-10 | 2021-03-10 | Cree, Inc. | Silicon carbide dimpled substrate |
US20070173471A1 (en) | 2006-01-24 | 2007-07-26 | Losordo Douglas W | Morphogen compositions and methods of use thereof to treat heart disorders |
US7405195B2 (en) | 2006-03-27 | 2008-07-29 | Natural Beauty Bio-Technology Limited | Cosmetic compositions |
EP2142206B1 (en) | 2007-03-30 | 2014-07-30 | The Cleveland Clinic Foundation | SDF-1 for use in the treatment of ischemic peripheral vascular disorders |
US20100272679A1 (en) | 2007-12-14 | 2010-10-28 | Penn Marc S | Compositions and methods of promoting wound healing |
CA2772610C (en) | 2009-08-28 | 2018-01-23 | The Cleveland Clinic Foundation | Sdf-1 delivery for treating ischemic tissue |
WO2012037083A2 (en) | 2010-09-15 | 2012-03-22 | The Cleveland Clinic Foundation | Compositions and method for promoting musculoskeletal repair |
US20120068161A1 (en) | 2010-09-16 | 2012-03-22 | Lee Keon-Jae | Method for forming graphene using laser beam, graphene semiconductor manufactured by the same, and graphene transistor having graphene semiconductor |
JP5569376B2 (ja) | 2010-12-07 | 2014-08-13 | 住友電気工業株式会社 | 半導体装置の製造方法 |
-
2010
- 2010-08-30 CA CA2772610A patent/CA2772610C/en not_active Expired - Fee Related
- 2010-08-30 CN CN201080043895.7A patent/CN102740894B/zh active Active
- 2010-08-30 WO PCT/US2010/047175 patent/WO2011026041A2/en active Application Filing
- 2010-08-30 BR BR112012004395A patent/BR112012004395B8/pt not_active IP Right Cessation
- 2010-08-30 MX MX2012002610A patent/MX357779B/es active IP Right Grant
- 2010-08-30 US US13/393,141 patent/US20120283315A1/en not_active Abandoned
- 2010-08-30 EP EP10812718.4A patent/EP2473196B1/en not_active Not-in-force
- 2010-08-30 AU AU2010286511A patent/AU2010286511B2/en not_active Ceased
- 2010-08-30 JP JP2012527071A patent/JP5856059B2/ja active Active
-
2012
- 2012-07-24 US US13/556,639 patent/US8513007B2/en active Active
- 2012-07-24 US US13/556,595 patent/US8513213B2/en active Active
-
2013
- 2013-06-07 US US13/912,435 patent/US8883756B2/en active Active
- 2013-12-09 US US14/100,050 patent/US9844581B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP2473196A4 (en) | 2015-01-07 |
US8513213B2 (en) | 2013-08-20 |
US8513007B2 (en) | 2013-08-20 |
US9844581B2 (en) | 2017-12-19 |
US20120289586A1 (en) | 2012-11-15 |
EP2473196B1 (en) | 2017-05-31 |
US20130303597A1 (en) | 2013-11-14 |
CN102740894A (zh) | 2012-10-17 |
JP5856059B2 (ja) | 2016-02-09 |
US20140135383A1 (en) | 2014-05-15 |
WO2011026041A9 (en) | 2011-07-21 |
CA2772610A1 (en) | 2011-03-03 |
AU2010286511A1 (en) | 2012-04-12 |
MX357779B (es) | 2018-07-24 |
US8883756B2 (en) | 2014-11-11 |
WO2011026041A2 (en) | 2011-03-03 |
US20120283315A1 (en) | 2012-11-08 |
BR112012004395B1 (pt) | 2021-01-12 |
US20120289585A1 (en) | 2012-11-15 |
AU2010286511B2 (en) | 2016-05-26 |
EP2473196A2 (en) | 2012-07-11 |
CN102740894B (zh) | 2015-07-15 |
CA2772610C (en) | 2018-01-23 |
BR112012004395B8 (pt) | 2021-05-25 |
JP2013503202A (ja) | 2013-01-31 |
MX2012002610A (es) | 2012-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012004395A2 (pt) | liberação de sdf-1 para tratamento do tecido isquêmico | |
HK1178036A1 (zh) | 組織擴張器 | |
BR112012000687A2 (pt) | tesoura para um endoscópio | |
UY33094A (es) | Procedimiento para la preparacion de dronedarona | |
FR2941143B1 (fr) | Agrafe chirurgicale auto-agrippante | |
ES2973642T3 (es) | Sistema para ablación de tejido | |
IL217339A0 (en) | Devices and methods for tissue engineering | |
BR112012009021A2 (pt) | dispositivo de cuidados para tecidos | |
BR112012008426A2 (pt) | endoscópio rígido em formato de bastão para aplicações médicas | |
IL218663A0 (en) | Devices and methods for tissue engineering | |
BR112012004807A2 (pt) | vacina para pcsk9 | |
BRPI0909780A2 (pt) | Composições e métodos para liberação de fármaco | |
BR112012004979A2 (pt) | composições para o tratamento de semente e métodos | |
ES2700843T8 (es) | Herramientas dentales para cirugía guiada | |
BR112013028856A2 (pt) | pinça para fixação de fraturas em ossos | |
BRPI1012638A2 (pt) | métodos e intermediários para preparar agentes farmacêuticos | |
BR112012001819A2 (pt) | métodos para tratamento de dor | |
BRPI1008566A8 (pt) | métodos e composições para o diagnóstico e tratamento de câncer | |
BR112012002269A2 (pt) | implemento para tratar superfície | |
BRPI1007972A2 (pt) | composições de combinação e métodos para o tratamento de câncer | |
BRPI1008564A2 (pt) | métodos e composições para o dignóstico e tratamento de câncer | |
BR112012004836A2 (pt) | pirazinilpiridinas úteis para o tratamento de doenças proliferativas | |
BR112012002360A2 (pt) | dispositivo para ostomia de duas peças | |
PL2398406T3 (pl) | Szczypczyki chirurgiczne | |
BR112012008959A2 (pt) | tratamento de terapia de combinação para infecções virais |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Ipc: A61K 38/19 (2006.01), A61K 9/00 (2006.01), A61K 31 |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 12/01/2021, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/08/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 12A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2685 DE 21-06-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |